respiratory
Lung cancer

Row over lung cancer drug deal


The Opposition has questioned why the government gave a drug company a special pricing deal for its lung cancer drug, against the advice of the PBAC. Labor has accused Health Minister Greg Hunt of “cherry picking” the PBAC’s recommendations after he allegedly signed off on a “special pricing arrangement” (SPA) for the tyrosine kinase inhibitor ...

Already a member?

Login to keep reading.


OR
© 2018 the limbic